HomeNDC LookupIngredients › Bromocriptine Mesylate
📦 NDC / package directory — not a drug information page

Bromocriptine Mesylate NDCs, Package Codes, Strengths & Labelers

This page lists NDC package records for Bromocriptine Mesylate products — strengths, dosage forms, package sizes, labelers, 11-digit billing NDCs, pricing data when available, and links to each individual NDC page. It’s an NDC/package & billing directory, not a clinical drug page.

Key stats

25
Package NDCs
18
Products
18
Active listings
0
Discontinued
12
Labelers
6
Strengths
3
Dosage forms
11
With NADAC pricing

By strength, form & labeler

NDC products by strength
BROMOCRIPTINE MESYLATE 5 mg/1 7
BROMOCRIPTINE MESYLATE 2.5 mg/1 7
BROMOCRIPTINE MESYLATE 1 kg/kg 1
BROMOCRIPTINE MESYLATE 25 kg/25kg 1
BROMOCRIPTINE MESYLATE 1 g/g 1
BROMOCRIPTINE MESYLATE .8 mg/1 1
By dosage form
TABLET 8
CAPSULE 7
POWDER 3
Top labelers
ANI Pharmaceuticals, Inc. 6
Zydus Pharmaceuticals USA Inc. 2
American Health Packaging 1
Avvisto Therapeutics LLC 1
Curia Italy S.r.l. 1
Mylan Pharmaceuticals Inc. 1
Padagis US LLC 1
Professional Compounding Centers o... 1

Browse records — 18 products

Drug / product Billing NDC NADAC / unit Status
Bromocriptine mesylate 5 mg/1 CAPSULE Zydus · NDC 68382-0110-01 · 100 CAPSULE in 1 BOTTLE (68382-110-01) 68382-0110-01 On market View →
BROMOCRIPTINE MESYLATE 1 kg/kg POWDER Professional · NDC 51927-2274-00 · 1 kg in 1 CONTAINER (51927-2274-0) 51927-2274-00 On market View →
Bromocriptine mesylate 2.5 mg/1 TABLET Sandoz · NDC 00781-5325-01 · 100 TABLET in 1 BOTTLE (0781-5325-01) 00781-5325-01 $1.889 /unit · NADAC On market View →
Bromocriptine Mesylate 2.5 mg/1 TABLET ANI · NDC 70954-0978-10 · 30 TABLET in 1 BOTTLE (70954-978-10) 70954-0978-10 $1.606 /unit · NADAC On market View →
Bromocriptine Mesylate 2.5 mg/1 TABLET American · NDC 60687-0931-21 · 30 BLISTER PACK in 1 CARTON (60687-931-21) / 1 TABLET in 1 BLISTER PACK (60687-931-11) 60687-0931-21 $1.606 /unit · NADAC On market View →
BROMOCRIPTINE MESYLATE 25 kg/25kg POWDER Curia · NDC 55486-1561-00 · 50 kg in 1 DRUM (55486-1561-0) 55486-1561-00 On market View →
Bromocriptine Mesylate 1 g/g POWDER Qingdao · NDC 73212-0035-01 · 1 g in 1 BOTTLE (73212-035-01) 73212-0035-01 On market View →
Bromocriptine Mesylate 5 mg/1 CAPSULE ANI · NDC 70954-0951-10 · 30 CAPSULE in 1 BOTTLE (70954-951-10) 70954-0951-10 On market View →
Bromocriptine Mesylate 5 mg/1 CAPSULE Mylan · NDC 00378-7096-01 · 100 CAPSULE in 1 BOTTLE, UNIT-DOSE (0378-7096-01) 00378-7096-01 $4.117 /unit · NADAC On market View →
Bromocriptine mesylate 2.5 mg/1 TABLET REMEDYREPACK · NDC 70518-4628-00 · 50 POUCH in 1 BOX (70518-4628-0) / 1 TABLET in 1 POUCH (70518-4628-1) 70518-4628-00 On market View →
Bromocriptine mesylate 5 mg/1 CAPSULE Zydus · NDC 65841-0654-01 · 100 CAPSULE in 1 BOTTLE (65841-654-01) 65841-0654-01 On market View →
Bromocriptine mesylate 2.5 mg/1 TABLET Padagis · NDC 00574-0106-01 · 100 TABLET in 1 BOTTLE, PLASTIC (0574-0106-01) 00574-0106-01 $1.606 /unit · NADAC On market View →
Bromocriptine Mesylate 2.5 mg/1 TABLET ANI · NDC 70954-0978-10 · 30 TABLET in 1 BOTTLE (70954-978-10) 70954-0978-10 $1.606 /unit · NADAC On market View →
Bromocriptine Mesylate 5 mg/1 CAPSULE ANI · NDC 70954-0951-10 · 30 CAPSULE in 1 BOTTLE (70954-951-10) 70954-0951-10 On market View →
Bromocriptine Mesylate 5 mg/1 CAPSULE ANI · NDC 70954-0951-10 · 30 CAPSULE in 1 BOTTLE (70954-951-10) 70954-0951-10 On market View →
Bromocriptine Mesylate 2.5 mg/1 TABLET ANI · NDC 70954-0978-10 · 30 TABLET in 1 BOTTLE (70954-978-10) 70954-0978-10 $1.606 /unit · NADAC On market View →
Bromocriptine mesylate 5 mg/1 CAPSULE Zydus · NDC 68382-0110-01 · 100 CAPSULE in 1 BOTTLE (68382-110-01) 68382-0110-01 On market View →
CYCLOSET bromocriptine mesylate .8 mg/1 TABLET Avvisto · NDC 73515-0123-21 · 21 TABLET in 1 BOTTLE (73515-123-21) 73515-0123-21 On market View →
Where does this data come from?
NDC package records, strengths, forms and labelers come from the openFDA NDC Directory; pricing is CMS NADAC. Grouped by active-ingredient name. This is package/billing reference data, not clinical drug information.